ANTIMICROBIAL REGENERATION CONSORTIUM

INNOVATING ANTIMICROBIALS FOR TODAY AND TOMORROW

Collaborative teams driving drug discovery and development from start to finish
  • Home
  • Mission
  • Our Team
  • Technology
  • Get involved
  • ARMOR
  • News
  • Stories across the globe
"We are the group that is chasing infections and finding  innovative solutions that solve the problem."

​ARC is a team of scientists across academia and industry who are ready to fight the war against pathogens. Our goal is to develop innovative, adaptable, and tunable therapeutics to combat drug-resistant and evolving pathogens. At ARC Labs, we believe that in order to counter smart pathogens, not only do we need new and effective therapeutics, but ones capable of eliminating drug-resistant pathogens, and those that can evolve as pathogens evolve. Thus, we use science and engineering approaches to create innovative, effective, smart therapies that can be delivered quickly, and someday in real-time. We achieve this by developing robust and fast design algorithms, easily manufactured and scalable chemistries, and high-throughput testing models. We envision a future of global health security by responding to evolving microbes with revolutionary, dynamic therapies. ARC is comprised of the following divisions.

ARC DIVISIONS

Picture



MEET OUR TEAM:

RESEARCH SCIENTISTS:

Anushree Chatterjee, Ph.D., Founder ARC, Antimicrobial Engineering, University of Colorado at Boulder, Colorado
Prashant Nagpal, Ph.D.
, co-founder ARC, Quantum Biology,  University of Colorado at Boulder, Colorado
Dr. Nancy Madinger, M.D., Clinical Microbiologist, Anschutz Medical Campus, University of Colorado at Denver, Colorado

Nitin Baliga, Ph.D., Systems Biology, Institute of Systems Biology, Seattle, Washington
Naeha Subramanian, Ph.D., Immunology and Host-Pathogen interactions, Institute of Systems Biology, Seattle, Washington
Teruna Siahaan, Ph.D., Pharmaceutical Chemistry, University of Kansas, Kansas
Micheal Hageman, Ph.D., Product Development, University of Kansas, Kansas
Robert Gilmore, Ph.D., Host-pathogen biology and Lyme Disease, Vector Borne Disease Center, Center for Disease Control and Prevention, Fort Collins, Colorado
Abhinav Shrestha,  Ph.D., In vitro Diagnostics, Dhiti Life Sciences Pvt. Ltd., and Oscar Medcare, New Delhi, India
Dr. Rama Chaudhary, M.D., Bacteriology and Pathology, All India Institute of Medical Sciences, New Delhi, India
William G. Pitt, Ph.D., Drug delivery and Diagnostics, Brigham Young University

Dr. Michelle A. Barron, M.D., Medical Director, Infection Control and Prevention, Division of Infectious Diseases, University of Colorado Hospital, Denver

Sean Gibbons, Ph.D., Gut Microbiome and Computational biology, Microbial Systems Ecology and Evolution, Institute of Systems Biology, Seattle, USA
Aaron Anselmo, Ph. D., Drug delivery and Gut microbiome, Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
Tanya Parish, Ph.D., Drug Discovery and TB research, Senior Vice President, Drug Discovery, Infectious Disease Research Institute, Seattle, USA.  
LactoBio, Inc., Microbial solutions and probiotics, Copenhagen Bio Science Park, Ole Maaloevej 3, DK-2200 Copenhagen, Denmark.
Reba Kanungo, Ph.D., Dean Research and Head of Clinical Microbiology, Department of Microbiology, Pondicherry Institute of Medical Sciences, India.
Pallab Ray, Ph.D., Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Dr. Gagandeep Singh, M.D., M.A.M.S., Mycology, Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Dr. Arti Kapil, M.D., Ph.D.,  Mechanism of antimicrobial resistance, Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Dr. Vijaya Lakshmi Nag, Professor and Head, Department of Microbiology, All India Institute of Medical Sciences Jodhpur- Rajasthan, India.
Dr. Hitender Gautum, M.D., Ph.D., Bacteriology and Serology Section, Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Vastbiome Inc., Gut microbiome and Therapeutics, San Carlos, CA, USA.



ARC VOLUNTEERS:

Dana Stamo, Masters student, Chemical and Biological Engineering, University of Colorado Boulder, CO, USA
Jocelyn Campos, Biochemist, Staff Scientist, University of Colorado Boulder, CO, USA

Sandra Sonoda, RN, BSN, Ph.D., Occupational Health Services at Wardenburg Health Center, University of Colorado Boulder, CO, USA
Stacy Farman,  BSN, CIC, Occupational Health Services at Wardenburg Health Center, University of Colorado Boulder, CO, USA
Antoni E. Bordoy, Ph.D., Chemical Engineer, Barcelona, Spain
Peter B. Otoupal, Ph.D., Chemical Engineer, California, USA
Colleen M. Courtney, Ph.D., Chemical Engineer, California, USA
Rodica Stamo, Assisted Living Facility Manager, USA

Kaylan Stinson, MSPH, Regional Epidemiologist, Boulder County Public Health
Arthur Ngyugen, ARMOR CU Boulder, University of Colorado Boulder, USA
Colleen Rei McCollum, ARMOR CU Boulder, University of Colorado Boulder, USA
Kristen A. Eller, ARMOR CU Boulder, University of Colorado Boulder, USA
Nolan O'Connor, ARMOR CU Boulder, University of Colorado Boulder, USA
Vismaya Bachu, ARMOR CU Boulder, University of Colorado Boulder, USA
Thomas Aunins, ARMOR CU Boulder, University of Colorado Boulder, USA
Kameron Korbe, ARMOR CU Boulder, University of Colorado Boulder, USA
Aaron Wesche, ARMOR CU Boulder, University of Colorado Boulder, USA
Max Levy, ARMOR CU Boulder, University of Colorado Boulder, USA

CONTACT/​FOLLOW US    | 
Powered by Create your own unique website with customizable templates.
  • Home
  • Mission
  • Our Team
  • Technology
  • Get involved
  • ARMOR
  • News
  • Stories across the globe